Data Mining Approach to Estimate the Duration of Drug Therapy from Longitudinal Electronic Medical Records
暂无分享,去创建一个
[1] K. Khunti,et al. Association of smoking and concomitant metformin use with cardiovascular events and mortality in people newly diagnosed with type 2 diabetes , 2016, Journal of diabetes.
[2] M. Toumi,et al. Comparison Of Comorbidity Measures To Predict Economic Outcomes In A Large Uk Primary Care Database. , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[3] From Checklists to Tools: Lowering the Barrier to Better Research Reporting , 2015, PLoS medicine.
[4] J. West,et al. Calculating Total Health Service Utilisation and Costs from Routinely Collected Electronic Health Records Using the Example of Patients with Irritable Bowel Syndrome Before and After Their First Gastroenterology Appointment , 2015, PharmacoEconomics.
[5] David Moher,et al. The REporting of Studies Conducted Using Observational Routinely-Collected Health Data (RECORD) Statement: Methods for Arriving at Consensus and Developing Reporting Guidelines , 2015, PloS one.
[6] K. Khunti,et al. Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes , 2015, Cardiovascular Diabetology.
[7] Remle Newton-Dame,et al. The state of population health surveillance using electronic health records: a narrative review. , 2015, Population health management.
[8] Mike Rayner,et al. The epidemiology of cardiovascular disease in the UK 2014 , 2015, Heart.
[9] J. Denny,et al. Extracting research-quality phenotypes from electronic health records to support precision medicine , 2015, Genome Medicine.
[10] Michael Klompas,et al. Uses of electronic health records for public health surveillance to advance public health. , 2015, Annual review of public health.
[11] K. Klein,et al. The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study , 2015, Cardiovascular Diabetology.
[12] K. Khunti,et al. Hypoglycemia and Risk of Cardiovascular Disease and All-Cause Mortality in Insulin-Treated People With Type 1 and Type 2 Diabetes: A Cohort Study , 2014, Diabetes Care.
[13] Emmanouel Garoufallou,et al. The Effectiveness of Big Data in Health Care: A Systematic Review , 2014, MTSR.
[14] Use of electronic medical records for clinical research in the management of type 2 diabetes. , 2014, Research in social & administrative pharmacy : RSAP.
[15] M. Etminan. Reporting guidelines for pharmacoepidemiological studies are urgently needed , 2014, BMJ : British Medical Journal.
[16] S. Gudbjörnsdottir,et al. Albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with type 2 diabetes: A nationwide observational study from the Swedish National Diabetes Register , 2013, Diabetes & vascular disease research.
[17] R. Hansen,et al. Real-world utilization patterns and outcomes of colesevelam hcl in the ge electronic medical record , 2013, BMC Endocrine Disorders.
[18] K Furu,et al. The Nordic prescription databases as a resource for pharmacoepidemiological research—a literature review , 2013, Pharmacoepidemiology and drug safety.
[19] J. Meyers,et al. Real-world comparative outcomes of US type 2 diabetes patients initiating analog basal insulin therapy , 2013, Current medical research and opinion.
[20] Hua Xu,et al. Comparative analysis of pharmacovigilance methods in the detection of adverse drug reactions using electronic medical records , 2013, J. Am. Medical Informatics Assoc..
[21] Carrie McAdam-Marx,et al. Application of electronic medical record data for health outcomes research: a review of recent literature , 2013, Expert review of pharmacoeconomics & outcomes research.
[22] Miriam Sturkenboom,et al. Postmarketing Safety Surveillance , 2013, Drug Safety.
[23] Preciosa M. ColomaGianluca Trifiro. Where does Signal Detection Using Electronic Healthcare Records Fit into the Big Picture , 2013 .
[24] J. A. Sánchez,et al. Epidemiology of cardiovascular disease , 2013 .
[25] Joshua C. Denny,et al. Chapter 13: Mining Electronic Health Records in the Genomics Era , 2012, PLoS Comput. Biol..
[26] Phil Aponte,et al. The effectiveness of implementing an electronic health record on diabetes care and outcomes. , 2012, Health services research.
[27] S. Brunak,et al. Mining electronic health records: towards better research applications and clinical care , 2012, Nature Reviews Genetics.
[28] A. Martins,et al. Overview of Pharmacoepidemiological Databases in the Assessment of Medicines Under Real-Life Conditions , 2012 .
[29] P. Home,et al. A comparison of duration of first prescribed insulin therapy in uncontrolled type 2 diabetes. , 2011, Diabetes research and clinical practice.
[30] Lisa A. Grabenbauer,et al. Electronic Health Record Adoption – Maybe It’s not about the Money , 2011, Applied Clinical Informatics.
[31] I. Petersen,et al. Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years. , 2011, Rheumatology.
[32] O. Baser,et al. A real-world study of patients with type 2 diabetes initiating basal insulins via disposable pens , 2011, Advances in therapy.
[33] Heather N. Watson,et al. Use of electronic medical records (EMR) for oncology outcomes research: assessing the comparability of EMR information to patient registry and health claims data , 2011, Clinical epidemiology.
[34] Lixia Yao,et al. Electronic health records: Implications for drug discovery. , 2011, Drug discovery today.
[35] N. Menachemi,et al. Benefits and drawbacks of electronic health record systems , 2011 .
[36] Prakash M. Nadkarni,et al. Drug safety surveillance using de-identified EMR and claims data: issues and challenges , 2010, J. Am. Medical Informatics Assoc..
[37] Pierre Zweigenbaum,et al. Extracting medical information from narrative patient records: the case of medication-related information , 2010, J. Am. Medical Informatics Assoc..
[38] Albert G Crawford,et al. Comparison of GE Centricity Electronic Medical Record database and National Ambulatory Medical Care Survey findings on the prevalence of major conditions in the United States. , 2010, Population health management.
[39] C. Mullins,et al. Perspectives on electronic medical records adoption: electronic medical records (EMR) in outcomes research. , 2010, Patient related outcome measures.
[40] B. Dean,et al. Review: Use of Electronic Medical Records for Health Outcomes Research , 2009, Medical care research and review : MCRR.
[41] A. Majeed,et al. Identifying undiagnosed diabetes: cross-sectional survey of 3.6 million patients' electronic records. , 2008, The British journal of general practice : the journal of the Royal College of General Practitioners.
[42] Jessica S. Ancker,et al. Redesigning electronic health record systems to support public health , 2007, J. Biomed. Informatics.
[43] Chengqi Zhang,et al. Data preparation for data mining , 2003, Appl. Artif. Intell..
[44] M. Dixon,et al. - 1-Preparing Clean Views of Data for Data Mining , 2000 .